Abstract A 48-year-old man with chronic lymphocytic leukemia presented with nephrotic syndrome, hematuria, and mild deterioration of renal function. Further analysis using serum immunofixation electrophoresis detected monoclonal immunoglobulin (Ig) M-j and IgG-j M-protein. Testing for cryoglobulin in serum was negative. Light microscopy of a renal biopsy specimen showed membranoproliferative glomerulonephritis features with marked mononuclear cell infiltration in the interstitium. On immunofluorescence study, the deposition of IgM heavy chain was predominantly observed with the same distribution of j light chain, whereas no k light chain was found. Electron microscopy revealed fine granular deposits in the mesangial, subendothelial, and subepithelial areas, mimicking those observed in the immune complex-mediated glomerulonephritis. These pathological findings were consistent with recently described cases of proliferative glomerulonephritis with monoclonal IgG deposits. Thus, monoclonal IgM deposition can also cause proliferative glomerulonephritis.
Introduction
Renal involvement in chronic lymphocytic leukemia/small lymphocytic leukemia (CLL/SLL) is relatively uncommon. In cases with these conditions, nephrotic syndrome is frequently observed [1] . Although the etiology varies, the most frequent lesion found on kidney biopsy is membranoproliferative glomerulonephritis (MPGN) feature, which is caused by the deposition of abnormal immunoglobulin (Ig) secreted by leukemia B cells [1, 2] .
Abnormal monoclonal Ig deposition can cause various glomerular lesions. Of these, proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID), recently described by Nasr et al., was characterized by diffuse endocapillary proliferative or membranoproliferative-like glomerulonephritis with fine granular deposits, mimicking immune complex-type deposits on electron microscopy [3] . This new concept of the glomerular disease has expanded the disease spectrum. Some rare cases were associated with hematological disorders, such as multiple myeloma, amyloid light chain (AL) amyloidosis, or CLL/SLL [4, 5] . Moreover, monoclonal IgA deposition may also develop into the new form of proliferative glomerulonephritis [6] .
Herein, we describe a rare case of CLL/SLL showing MPGN with monoclonal IgM-j deposition. The analysis of ultrastructural features revealed non-organized deposits in the mesangial, subendothelial, and subepithelial areas. These findings led us to label the disorder as proliferative glomerulonephritis with monoclonal IgM deposits (PGNMIMD).
Case report
A 48-year-old man with no significant medical history was admitted to our hospital because of legs edema with heavy proteinuria and hematuria. On admission, physical examination revealed marked edema in bilateral lower legs. Urinalysis showed a proteinuria level of 4.8 g/24 h and more than 100 red blood cells/high-power field. Laboratory tests found an elevated serum creatinine level of 1.34 mg/dL, total serum protein level of 4.7 g/dL, and serum albumin level of 2.4 g/dL. The serum C3 level was slightly decreased to 78 mg/dL (normal range 85-160 mg/dL), although the serum C4 level and total serum hemolytic activity were within normal ranges. Other laboratory findings were as follows: leukocyte count, 9.65 9 10 3 /lL with 30.7 % lymphocyte; erythrocyte count, 6.29 9 10 6 /lL; hemoglobin, 17.8 g/dL; hematocrit, 55.1 %; platelet count, 269 9 10 3 /lL; blood urea nitrogen, 23 mg/dL; uric acid, 7.0 mg/dL; total cholesterol, 289 mg/dL; triglycerides, 243 mg/dL; C-reactive protein, 0.39 mg/dL; serum IgG, 311 mg/dL; serum IgA, 164 mg/dL; and serum IgM, 147 mg/dL. Hepatobiliary function was normal, and blood glucose was within the normal range. Tests for hepatitis B and C, antinuclear antibody, anti-double-stranded DNA antibody, cryoglobulin, myeloperoxidase antineutrophil cytoplasmic antibody (ANCA), protease-3 ANCA, and rheumatoid factor were all negative. The soluble interleukin-2 receptor level was elevated to 4370 U/mL (normal range 145-519 U/mL). Serum immunofixation electrophoresis (IFE) revealed a band positive for IgM-j and IgG-j M-protein. Urinary IFE also showed weak bands of IgG-j and j-type Bence Jones protein. Computed tomography revealed no evidence of lymph node swelling. Renal biopsy was performed for accurate diagnosis.
Thirty-one glomeruli were microscopically examined, eight of which showed global sclerosis. The remaining glomeruli exhibited a diffuse increase of mesangial cells and focal endocapillary proliferation accompanying periodic acid-Schiff-positive intracapillary thrombi. Most of the basement membrane in the glomeruli became thickened with the formation of double contours (Fig. 1a) . In one glomerulus, cellular crescent was observed. Prominent infiltration of lymphocytes with focal and clustered distribution was also observed in the interstitium. Marked intensity for IgM heavy chain (3?) and C3 (2?), and weak intensity for C1q (?) in both the mesangium and capillary walls were demonstrated by immunofluorescence (IF) study (Fig. 1b) . In contrast, the IF test was negative for IgG (-) and showed weak intensity for IgA (?) (Fig. 1c) . The IF test for j light chains was positive (2?) in the mesangium and along the capillary walls without staining for k light chain (-) (Fig. 1d, e) . Electron microscopy revealed diffuse, finely granular but not fibrillary electron-dense deposits resembling immune complex deposits in the mesangial, subendothelial, and subepithelial areas (Fig. 2a, b) .
Further immunohistochemical analyses using paraffinembedded sections of renal biopsy specimens showed that the infiltrated lymphocytes were positive for CD20, CD79a, and CD5 (Fig. 3a) . The same immunophenotyping B cell population was also detected in blood by flow cytometry. More importantly, fluorescence in situ hybridization analysis of paraffin-embedded sections (PS-FISH) of the renal biopsy specimen detected Ig heavy chain rearrangement (Fig. 3b) . Cytological evaluation of aspirated bone marrow showed 40.8 % mature leukemic lymphocytes without plasma cell proliferation.
Therefore, the present case was diagnosed as CLL/SLL concomitant with type III MPGN secondary to monoclonal IgM-j deposition. Monthly combination therapy of rituximab (500 mg/m 2 on day 1), fludarabine (30 mg/m 2 on days 1-3), and cyclophosphamide (750 mg/m 2 on days 1-3) was administered. Four courses of this regimen resulted in hematological remission, together with a reduction in the protein/creatinine ratio of 2 g/g. Serum creatinine was 1.5 mg/dL, indicating no significant change in renal function.
Discussion
We described a case of CLL/SLL presenting with nephrotic syndrome. Renal biopsy findings showed an MPGN lesion that was consistent with the profile of PGNMID. More interestingly, proliferative glomerulonephritis was caused by monoclonal IgM secretion and deposition, which is rare.
CLL/SLL rarely exhibits various glomerular lesions, including MPGN, minimal change disease, amyloidosis, focal segmental sclerosis, and crescentic glomerulonephritis associated with ANCA [1, 2, 5, [7] [8] [9] [10] [11] [12] . Of them, we identified sixteen cases of secondary MPGN associated with CLL/SLL [1, 2, 5, [7] [8] [9] [10] . Cryoglobulinemia was found in six of these cases, of which two cases were type I (IgG1k and IgGj), two cases were type II (IgG-IgM and IgG-IgA), one case was type III (IgG-IgM), and one case was undetermined. Of the other cases, one case was diagnosed with fibrillary/immunotactoid glomerulopathy (IgG) and two cases were diagnosed with proliferative glomerulonephritis with monoclonal IgG deposits (IgG1k and IgG1j). In contrast, the present case showed unique pathological findings, monoclonal IgM deposition mediated The arrows show distinct red (centromere site) and green (telomere site) split signals in nuclei, suggesting IgH gene rearrangement glomerulonephritis, with the absence of clinical and laboratory findings of cryoglobulin. Only one similar case has been reported previously, in the study by Sethi et al. [10] .
The deposition of monoclonal Ig containing light and heavy chains with non-organized deposits usually occurs in light and heavy chain deposition disease (LHCDD), which is characterized by nodular mesangial glomerulosclerosis resembling Kimmelstiel-Wilson nodules and the continuous deposition of fine granular electron-dense materials along the inner aspect of glomerular or tubular basement membranes [13] . These findings are entirely different from those observed in the present case. Thus, LHCDD was Waldenström's macroglobulinemia is well known as an IgM-secreting hematological disorder. In addition, B cell lymphoma, CLL, or multiple myeloma also show the same hematological property [15] . Although glomerulopathy secondary to monoclonal IgM deposition is rare, the most characteristic lesion is intracapillary deposits of IgM with or without cryoglobulinemia and AL amyloidosis [15, 16] . Otherwise, immunotactoid/fibrillary glomerulopathy, cryoglobulinemia-related glomerulopathy, and light chain deposition disease were also reported [10, [17] [18] [19] . Furthermore, we could identify 19 cases suitable for the concept of PGNMIMD in the literature [10, 14, 15, [20] [21] [22] [23] .
Features of PGNMIMD are summarized in Table 1 . The mean age of patients was 62.5 years (range 38-83 years) and 16 out of 20 (80 %) were males. The average serum creatinine level at presentation was 2.37 mg/dL (range 1-5.6 mg/dL), and more than half of the patients (11/20, 55 %) showed nephrotic-range proteinuria ([3.0 g/24 h). Predominant deposition of IgM-j was significant. The most common entity was monoclonal gammopathy of undetermined significance. Waldenström's macroglobulinemia was present in three cases, B cell lymphoma in two cases, and CLL in two cases, including our case. Further accumulation of data is needed in order to adequately describe PGNMIMD. Careful evaluation by electron microscopy is essential for accurate diagnosis and categorization in paraproteinemia-associated nephropathy.
In conclusion, we described a case of PGNMIMD with CLL/SLL. This condition is relatively rare, but this case provides important information for classifying renal disorders in patients with plasma cell dyscrasia. PGNMID may not be restricted to cases with monoclonal IgG deposition. Therefore, expansion of the disease spectrum is required. The more accurate term of diagnosis in the present case was proliferative glomerulonephritis with monoclonal IgM deposits (PGNMIMD).
